Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTB4R2 | Q9NPC1 | 17/20 | 0.54 |
| ▸ | AGTR1 | P30556 | 2/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.45 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.45 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.45 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.45 |
| ▸ | OXTR | P30559 | 1/20 | 0.44 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1986 | 0.95 | LTB4R2 (0.53) | LTB4R2AGTR1HDAC3HDAC1HDAC2 | |
| SCHEMBL2043 | 0.89 | LTB4R2 (0.55) | LTB4R2AGTR1OXTRAVPR1A | |
| SCHEMBL2089 | 0.88 | LTB4R2 (0.55) | LTB4R2AGTR1HDAC3HDAC1HDAC2 | |
| SCHEMBL2730 | 0.88 | LTB4R2 (0.53) | LTB4R2AGTR1HDAC3HDAC1HDAC2 | |
| SCHEMBL2124 | 0.88 | LTB4R2 (0.54) | LTB4R2AGTR1HDAC3HDAC1HDAC2 | |
| SCHEMBL2454 | 0.87 | LTB4R2 (0.53) | LTB4R2AGTR1HDAC3HDAC1HDAC2 | |
| SCHEMBL1900 | 0.87 | LTB4R2 (0.53) | LTB4R2AGTR1HDAC3HDAC1HDAC2 | |
| SCHEMBL2071 | 0.86 | LTB4R2 (0.54) | LTB4R2AGTR1HDAC3HDAC1HDAC2 | |
| SCHEMBL9429910 | 0.86 | LTB4R2 (0.53) | LTB4R2AGTR1HDAC3HDAC1HDAC2 | |
| SCHEMBL2445 | 0.84 | LTB4R2 (0.53) | LTB4R2AGTR1OXTRAVPR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5965592-A | HYPOTENSIVE AGENTS | NOVARTIS CORPORATION (US) | 1999-10-12 | — | — | US | disclosed |
| EP-0443983-B1 | Acyl compounds | CIBA GEIGY AG (CH) | 1996-02-28 | — | — | EP | disclosed |
| US-5399578-A | Hypotensive; valsartan; high blood pressure and cardiac insufficiency | CIBA-GEIGY CORP (US) | 1995-03-21 | — | — | US | disclosed |
| EP-0443983-A1 | Acyl compounds | CIBA-GEIGY AG (CH) | 1991-08-28 | — | — | EP | disclosed |